• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].

作者信息

Huang Yi-Jung, Ho Kai-Wen, Cheng Tian-Lu, Wang Yen-Tseng, Chao Shi-Wei, Huang Bo-Cheng, Chao Yu-Shu, Lin Chia-Yu, Hsu Yun-Han, Chen Fang-Ming, Chuang Chih-Hung

机构信息

Department of Biochemistry, School of Post Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan.

Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Int J Biol Macromol. 2024 Nov;281(Pt 2):136259. doi: 10.1016/j.ijbiomac.2024.136259. Epub 2024 Oct 11.

DOI:
10.1016/j.ijbiomac.2024.136259
PMID:39395340
Abstract
摘要

相似文献

1
Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].《“IFNγ-伊匹单抗的选择性激活增强伊匹单抗的治疗效果和安全性”的勘误》[《国际生物大分子杂志》265(第2部分)(2024年4月)130945]
Int J Biol Macromol. 2024 Nov;281(Pt 2):136259. doi: 10.1016/j.ijbiomac.2024.136259. Epub 2024 Oct 11.
2
Corrigendum to "Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab" [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945].《“IFNγ-伊匹单抗的选择性激活增强伊匹单抗的治疗效果和安全性”勘误》[《国际生物大分子杂志》265(Pt 2)(2024年4月)130945]
Int J Biol Macromol. 2024 Sep 19;280(Pt 1):135670. doi: 10.1016/j.ijbiomac.2024.135670.
3
Corrigendum to "Protective effect of thymoquinone on glucose or methylglyoxal-induced glycation of superoxide dismutase" [Int. J. Biol. Macromol. 2014 Apr; 65: 16-20].《对“百里醌对葡萄糖或甲基乙二醛诱导的超氧化物歧化酶糖基化的保护作用”的勘误》[《国际生物大分子杂志》2014年4月；65卷：16 - 20页]
Int J Biol Macromol. 2019 Oct 15;139:1317. doi: 10.1016/j.ijbiomac.2019.08.232. Epub 2019 Sep 12.
4
Corrigendum to "Reasonable permutation of M2e enhances the effect of universal influenza nanovaccine" [Int. J. Biol. Macromol. 173 (2021) 244-250].《M2e 的合理排列增强通用流感纳米疫苗效果》的勘误[《国际生物大分子杂志》173 卷（2021 年）244 - 250 页]
Int J Biol Macromol. 2024 Apr;264(Pt 1):130290. doi: 10.1016/j.ijbiomac.2024.130290. Epub 2024 Mar 8.
5
Corrigendum to "Down-regulated miR-187 promotes oxidative stress-induced retinal cell apoptosis through P2X7 receptor" [Int. J. Biol. Macromol. 120(Pt A): (2018) 801-810].
Int J Biol Macromol. 2019 Aug 1;134:1219. doi: 10.1016/j.ijbiomac.2019.04.153. Epub 2019 Apr 30.
6
Corrigendum to "Structural insights into trypanosomatid Mnk kinase orthologues (kMnks) suggest altered mechanism in the kinase domain" [Int. J. Biol. Macromol. 277(Pt 3) (2024) 134428].对“锥虫Mnk激酶直系同源物（kMnks）的结构见解表明激酶结构域机制改变”[《国际生物大分子杂志》277卷第3期（2024年）134428]的勘误
Int J Biol Macromol. 2024 Nov;279(Pt 4):135530. doi: 10.1016/j.ijbiomac.2024.135530. Epub 2024 Sep 13.
7
Corrigendum to "Molecular mechanism of regulating tat protein expression of pingganjiedu TCM in the treatment of AIDS based on network pharmacology" [Int. J. Biol. Macromol. 278(Pt 1) (Aug 8, 2024) 134599].《基于网络药理学探讨平肝解毒中药治疗艾滋病调控tat蛋白表达的分子机制》勘误 [《国际生物大分子杂志》278(第1部分)(2024年8月8日)134599]
Int J Biol Macromol. 2024 Nov;281(Pt 1):136228. doi: 10.1016/j.ijbiomac.2024.136228. Epub 2024 Oct 4.
8
Corrigendum to "Chitosan-collagen biopolymer biofilm derived from cephalopod gladius; evaluation of osteogenesis, angiogenesis and wound healing for tissue engineering application" [Int. J. Biol. Macromol. 2024 Aug 26;279(Pt 1):135078].《头足类角质颚来源的壳聚糖-胶原蛋白生物聚合物生物膜；用于组织工程应用的成骨、血管生成和伤口愈合评估》的勘误[《国际生物大分子杂志》2024年8月26日；279(第1部分):135078]
Int J Biol Macromol. 2024 Nov;281(Pt 1):136104. doi: 10.1016/j.ijbiomac.2024.136104. Epub 2024 Oct 2.
9
Corrigendum to "Long non-coding RNA-ENST00000434223 suppresses tumor progression in gastric cancer cells through the Wnt/β-catenin signaling pathway" [Int. J. Biol. Macromol. 2018 Dec;120(Pt A):491-501].《“长链非编码RNA-ENST00000434223通过Wnt/β-连环蛋白信号通路抑制胃癌细胞肿瘤进展”的勘误》[《国际生物大分子杂志》2018年12月；120(A部分)：491-501]
Int J Biol Macromol. 2021 May 1;178:617. doi: 10.1016/j.ijbiomac.2021.03.131. Epub 2021 Apr 15.
10
Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumab.选择性激活 IFNγ-ipilimumab 可增强 ipilimumab 的治疗效果和安全性。
Int J Biol Macromol. 2024 Apr;265(Pt 2):130945. doi: 10.1016/j.ijbiomac.2024.130945. Epub 2024 Mar 16.